The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Falling costs and deeper genetic insights are accelerating adoption, creating opportunities in predictive diagnostics, pharmacogenomics and direct-to-consumer testing.Dublin, Sept. (GLOBE NEWSWIRE) -- ...

Jan. 14—ROCHESTER — Vyriad, a growing Rochester firm, recently raised an additional $25 million in funding to fuel its "race" to bring a new technology to market that accurately targets cancer within ...

Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific ...

Genetic technologies have the potential to help solve the ever-growing challenges of food insecurity and global health. But for this potential to be met, regulations that hinder scientific innovation ...

An online portal streamlines the testing process at UCLA Health. UCLA Health’s virtual genetic counseling tool has markedly increased the percentage of cancer patients undergoing recommended germline ...

The Dyno Frontiers Program has evolved into the Dyno Frontiers Network, a curated ecosystem connecting therapeutic developers advancing innovative payloads – including base and prime editors, ...

Stepping away from its billions-of-years-old role as a genetic blueprint, DNA is now embarking on a new journey as an active field agent within cells. This research by a team led by Professor Jongmin ...

On November 13, 2025, the Genetic Technology (Precision Breeding) Regulations 2025 (“2025 PB regulations”) took effect, completing the United Kingdom’s (UK’s) post-Brexit framework for gene-edited ...